genedrive plc (AIM: GDR), the near patient molecular diagnostics company, provides an update on the progress being made on the Genedrive®COV19-ID kit, its rapid point of care molecular test for
All eyes are on Okyo (OKYO) as the biotechnology company announced that the patent entitled “Methods and Systems for Designing and/or Characterizing Soluble Lipidated has been issued by the United
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces it will release its interim results for the six months ended 31 December 2021 on Tuesday, 29 March 2022.
Zak Mir takes a charting perspective on some of the most followed small caps on the London market. Today’s selection includes Avacta, Cizzle, Creo, Falcon, Gelion, Genedrive, i3 Energy, Invinity,
Zak Mir looks at the charts of some of the most followed London small caps. Today’s selection includes Bens, Bidstack, Distil, Emmerson, Eve, Ferro, Genedrive, Iofina, Microsaic, Orosur, SRT, Victoria.
Halt the use of inaccurate Chinese lateral flow tests, with most already banned by the likes of the FDA.
Nice to see The Telegraph picked up on the story Share Talk has been highlighting throughout December 2021 “Stopping use of Chinese inaccurate lateral flow tests and support UK homemade
Zak Mir looks at some of the most followed small caps in London from a technical perspective. Today’s selection includes Contango, Eurasia, Genedrive, Galileo, Ilika, Napster, Oxford Biodynamics, Pensana, Proton,
Zak Mir takes a charting view on some of the most followed stocks on the London market. Today’s selection includes Avacta, Abingdon, Asimilar, Anexo, Caspian, Dev, Genedrive, Mila, Online Blockchain,
Sensitivity and specificity data submitted meets MHRA requirements
There was one of the most eagerly awaited updates just ahead of the Christmas break.
